Srm Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.00 Cr
- Satisfied Charges ₹ 1.58 Cr
- Revenue Growth 959.54%
- Profit Growth -2851.45%
- Ebitda -2071.55%
- Net Worth -688.07%
- Total Assets 85.42%
About Srm Life Science
Srm Life Science Private Limited (SLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 December 2011 and has a history of 13 years and two months. Its registered office is in Bharuch, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹14.00 Cr. The company has closed loans amounting to ₹1.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Niravkumar Mali and Seema Mali serve as directors at the Company.
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2011PTC068159
- Company No.
068159
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Srm Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niravkumar Mali  | Director | 16-Jun-2014 | Current |
| Seema Mali | Director | 05-Apr-2021 | Current |
Financial Performance of Srm Life Science.
Srm Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 959.54% increase. The company also saw a substantial fall in profitability, with a 2851.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 688.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srm Life Science?
In 2023, Srm Life Science had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R. P. Intermediates Private LimitedNiravkumar Mali is a mutual person
- Rushap Pharmachem Private Limited
Niravkumar Mali is a mutual person
Charges (Loans)
₹140.00 M
₹15.80 M
Charges Breakdown by Lending Institutions
- Others : 14.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2022 | Others | ₹7.00 Cr | Open |
| 14 Feb 2022 | Others | ₹7.00 Cr | Open |
| 08 Apr 2013 | State Bank Of India | ₹7.90 M | Satisfied |
| 08 Apr 2013 | State Bank Of India | ₹7.90 M | Satisfied |
How Many Employees Work at Srm Life Science?
Unlock and access historical data on people associated with Srm Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srm Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srm Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
